I still rate HUYA as a "Buy," as it is valued by the market at a depressed forward P/S of 0.64x. 3Q2025 marked the third consecutive quarter of positive sales growth for HUYA. HUYA has finally reached an inflection point regarding operating profitability in this three-month period; it barely broke even in the preceding 2Q25 with an EBIT of RMB 0.35 million.

Chad Beynon, MacQuarie senior analyst, joins CNBC's 'The Exchange' to discuss outlooks on gaming stocks.

DoorDash, Inc. ( DASH ) Morgan Stanley 25th European Technology, Media & Telecom Conference November 13, 2025 11:00 AM EST Company Participants Ravi Inukonda - Chief Financial Officer Conference Call Participants Brian Nowak - Morgan Stanley, Research Division Presentation Brian Nowak Morgan Stanley, Research Division Good afternoon, everyone. Welcome to the final discussion we're going to have here at day 2 of the Morgan Stanley 2025 European TMT Conference, where we're very thrilled to have Ravi from DoorDash here to talk through everything going on in the industry.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX). If you currently own shares of Amylyx Pharmaceuticals stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=22470 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenleg.

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Zimmer Biomet Holdings, Inc. (“Zimmer” or the “Company”) (NYSE: ZBH) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ZIMMER BIOMET HOLDINGS, INC. (ZBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happ.

As the AI revolution accelerates, energy demand is emerging as both its greatest challenge and biggest opportunity. Bloom Energy's innovative fuel cell technology directly addresses this bottleneck.

Is the C stock worth holding on to as its overhaul, cost cuts, and private lending push drive growth and strengthen its long-term outlook? Let us find out.

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RCI Hospitality Holdings, Inc. (NASDAQ: RICK) between December 15, 2021 and September 16, 2025, both dates inclusive (the “Class Period”), of the important November 20, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

Roughly 3,200 St. Louis-area machinists ended a nearly more than three-month strike that curbed jet-fighter production.

Dominant mega-caps with low debt deserve investors' attention. In times of prosperity, waste is common—and often sets the stage for strong cash generation when the cycle turns. Novo is enacted solid counter-measures: the CVS deal, the crackdown on compounders, and aggressive cost cutting.

Atea Pharmaceuticals, Inc. ( AVIR ) Discusses Next-Generation Hepatitis C Treatment Developments and Clinical Advancements November 13, 2025 10:00 AM EST Company Participants Jean-Pierre Sommadossi - Founder, Chairman, CEO & President Janet Hammond - Chief Development Officer Maria Horga - Chief Medical Officer John Vavricka - Chief Commercial Officer Jonae Barnes - Senior Vice President of Investor Relations & Corporate Communications Conference Call Participants Jordan Feld Anthony Martinez Nancy Reau Eric Lawitz Tsan-Yu Hsieh - William Blair & Company L.L.C., Research Division Presentation Operator Good morning, and welcome to the Atea Pharmaceuticals Virtual KOL event.

Tidewater Midstream and Infrastructure Ltd. ( TWM:CA ) Q3 2025 Earnings Call November 13, 2025 12:00 PM EST Company Participants Ian Quartly - Interim Chief Financial Officer Jeremy Baines - CEO & Director Conference Call Participants Robert Hope - Scotiabank Global Banking and Markets, Research Division Maurice Choy - RBC Capital Markets, Research Division Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Tidewater Midstream and Infrastructure Limited and Tidewater Renewables Limited Third Quarter 2025 Financial Results Conference Call.

Oracle is increasingly relying on debt markets to fund the buildout of its artificial intelligence infrastructure. Investors are growing concerned, pushing the stock down more than 30% from its high in September.

DOCU's deepening ties with Microsoft and Salesforce strengthen its IAM platform and long-term growth potential.

After a powerful run earlier this year, investors may be wondering whether Powell Industries (POWL) can climb higher. The company has been one of the standout performers in the industrial space, benefiting from strong demand in electrical infrastructure.

After a strong multi-year rally, Synopsys (NASDAQ: SNPS) shares have pulled back in recent months, bringing the stock closer to a key technical support zone. The company, a leader in electronic design automation (EDA) software, has been a consistent performer, benefiting from the growing complexity of semiconductor design and rising demand for AI-driven chips.

Gentex (GNTX) has long been known for its automotive mirrors and smart glass technologies. But the company is becoming much more than that.

@LikeFolio's Landon Swan shows a divided social media picture in Meta Platforms (META). Where Instagram has grown in momentum, Facebook lagged.

PHILADELPHIA, PA / ACCESS Newswire / November 13, 2025 / There are moments in every emerging company's life cycle when the market forgets the work and fixates on the weather. Stocks swing, sentiment dips, algorithms overreact.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options If you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 13, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc. ("Tvardi" or the "Company") (NASDAQ: TVRD).